TAM
TNDM icon

Tocqueville Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Tocqueville Asset Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,500
Closed -$215K – 623
2022
Q3 		$215K Hold
4,500
– – ﹤0.01% 559
2022
Q2 		$266K Sell
4,500
-100
-2% -$8.21K ﹤0.01% 593
2022
Q1 		$535K Hold
4,600
– – 0.01% 504
2021
Q4 		$692K Hold
4,600
– – 0.01% 508
2021
Q3 		$549K Hold
4,600
– – 0.01% 518
2021
Q2 		$448K Buy
4,600
+100
+2% +$8.92K 0.01% 577
2021
Q1 		$397K Hold
4,500
– – 0.01% 589
2020
Q4 		$431K Hold
4,500
– – 0.01% 564
2020
Q3 		$511K Sell
4,500
-700
-13% -$73.5K 0.01% 486
2020
Q2 		$514K Sell
5,200
-3,050
-37% -$243K 0.01% 480
2020
Q1 		$531K Sell
8,250
-1,350
-14% -$94.6K 0.01% 446
2019
Q4 		$572K Buy
9,600
+1,350
+16% +$83.3K 0.01% 529
2019
Q3 		$487K Buy
8,250
+4,200
+104% +$268K 0.01% 567
2019
Q2 		$261K Sell
4,050
-1,500
-27% -$96.8K ﹤0.01% 705
2019
Q1 		$352K Sell
5,550
-8,000
-59% -$420K ﹤0.01% 650
2018
Q4 		$514K Sell
13,550
-500
-4% -$17.7K 0.01% 550
2018
Q3 		$602K Sell
14,050
-10,300
-42% -$360K 0.01% 584
2018
Q2 		$536K Sell
24,350
-15,450
-39% -$190K 0.01% 593
2018
Q1 		$197K Buy
+39,800
New +$128K ﹤0.01% 791
2017
Q4 		– Sell
-1,700
Closed -$12K – 829
2017
Q3 		$12K Sell
1,700
-1,240
-42% -$7.85K ﹤0.01% 804
2017
Q2 		$24K Buy
2,940
+200
+7% +$1.85K ﹤0.01% 781
2017
Q1 		$33K Buy
2,740
+325
+13% +$7.11K ﹤0.01% 792
2016
Q4 		$52K Sell
2,415
-7,725
-76% -$297K ﹤0.01% 791
2016
Q3 		$777K Buy
10,140
+300
+3% +$21.9K 0.01% 546
2016
Q2 		$742K Buy
9,840
+100
+1% +$8.05K 0.01% 553
2016
Q1 		$848K Buy
9,740
+1,285
+15% +$112K 0.01% 528
2015
Q4 		$999K Buy
8,455
+1,750
+26% +$174K 0.01% 546
2015
Q3 		$591K Buy
+6,705
New +$781K 0.01% 660

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Tocqueville Asset Management's TNDM Position: Q4 2022 in Review

Tocqueville Asset Management sold out of Tandem Diabetes Care (TNDM) in Q4 2022, closing a stake of 4,500 shares — an estimated $215K sold.

Tocqueville Asset Management first reported a position in TNDM in Q3 2015 and held it in 28 quarters. The position peaked at $999K in Q4 2015. 295 funds tracked by Wall St. Rank hold TNDM as of Q4 2022.

  • Tocqueville Asset Management reported no remaining Tandem Diabetes Care position as of Q4 2022 after selling out during the quarter.
  • Tocqueville Asset Management sold 4,500 Tandem Diabetes Care shares in Q4 2022, an estimated $215K.
  • Tocqueville Asset Management first reported a position in Tandem Diabetes Care in Q3 2015 and held it in 28 quarters.
  • Tocqueville Asset Management's Tandem Diabetes Care position peaked at $999K in Q4 2015.
  • 295 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2022.

Based on Tocqueville Asset Management's 13F filing for Q4 2022, filed 9 Feb 2023.